Stay updated on Influenza Prevention with Self-Amplifying RNA Clinical Trial
Sign up to get notified when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.

Latest updates to the Influenza Prevention with Self-Amplifying RNA Clinical Trial page
- Check2 days agoChange DetectedA consolidated Locations section listing study sites by state was added, including Arizona, California, Florida, Illinois, Nebraska, New York, Ohio, South Carolina, and Texas. Per-state location pages were removed and the revision updated to v3.3.3.SummaryDifference0.7%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page shows a Revision: v3.3.2 and removes Revision: v3.2.0. This is a minor site template update and does not affect study content such as the title, eligibility criteria, contacts, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedThe government funding lapse notice was removed from the page, removing language about potential delays. The previous notice warned that information may not be up to date and described the NIH Clinical Center's operating status.SummaryDifference0.3%

- Check52 days agoChange DetectedNo additions or deletions were detected on the page. The content appears unchanged.SummaryDifference0.3%

- Check74 days agoChange Detected- Added a prominent operating-status notice and a link guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check81 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page version identifier.SummaryDifference0.1%

Stay in the know with updates to Influenza Prevention with Self-Amplifying RNA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.